These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 11818501)
1. Domain interactions between coregulator ARA(70) and the androgen receptor (AR). Zhou ZX; He B; Hall SH; Wilson EM; French FS Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501 [TBL] [Abstract][Full Text] [Related]
2. Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Tan J; Hall SH; Hamil KG; Grossman G; Petrusz P; Liao J; Shuai K; French FS Mol Endocrinol; 2000 Jan; 14(1):14-26. PubMed ID: 10628744 [TBL] [Abstract][Full Text] [Related]
3. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595 [TBL] [Abstract][Full Text] [Related]
5. RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays. Gao T; Brantley K; Bolu E; McPhaul MJ Mol Endocrinol; 1999 Oct; 13(10):1645-56. PubMed ID: 10517667 [TBL] [Abstract][Full Text] [Related]
6. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743 [TBL] [Abstract][Full Text] [Related]
7. Structural features discriminate androgen receptor N/C terminal and coactivator interactions. Askew EB; Minges JT; Hnat AT; Wilson EM Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945 [TBL] [Abstract][Full Text] [Related]
8. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. Ikonen T; Palvimo JJ; Jänne OA J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054 [TBL] [Abstract][Full Text] [Related]
9. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032 [TBL] [Abstract][Full Text] [Related]
11. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111 [TBL] [Abstract][Full Text] [Related]
12. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Bai S; He B; Wilson EM Mol Cell Biol; 2005 Feb; 25(4):1238-57. PubMed ID: 15684378 [TBL] [Abstract][Full Text] [Related]
13. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2). Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543 [TBL] [Abstract][Full Text] [Related]
14. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. He B; Kemppainen JA; Wilson EM J Biol Chem; 2000 Jul; 275(30):22986-94. PubMed ID: 10816582 [TBL] [Abstract][Full Text] [Related]
15. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system. Wafa LA; Cheng H; Rao MA; Nelson CC; Cox M; Hirst M; Sadowski I; Rennie PS Biochem J; 2003 Oct; 375(Pt 2):373-83. PubMed ID: 12864730 [TBL] [Abstract][Full Text] [Related]
16. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor. Govindan MV Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476 [TBL] [Abstract][Full Text] [Related]
17. Involvement of three glutamine tracts in human androgen receptor transactivation. Harada N; Mitani T; Higashimura Y; Yamaji R; Okamoto K; Nakano Y; Inui H J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):77-84. PubMed ID: 19833203 [TBL] [Abstract][Full Text] [Related]
18. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Alen P; Claessens F; Verhoeven G; Rombauts W; Peeters B Mol Cell Biol; 1999 Sep; 19(9):6085-97. PubMed ID: 10454556 [TBL] [Abstract][Full Text] [Related]
19. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987 [TBL] [Abstract][Full Text] [Related]
20. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]